Status:
COMPLETED
Ultrasound Impact in Rheumatoid Arthritis Patient Reported Outcomes
Lead Sponsor:
Clínica de Artritis Temprana
Collaborating Sponsors:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Conditions:
Rheumatoid Arthritis
Patient Reported Outcomes
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.
Eligibility Criteria
Inclusion
- A clinical diagnosis of RA made at the discretion of the attending experienced rheumatologist.
- Patients classified in remission/low disease activity
Exclusion
- \<16 years old.
- Patient with recent trauma in the evaluated joints.
- Luxation in the MCP, PIP or MTP joints.
Key Trial Info
Start Date :
May 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2019
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT03228342
Start Date
May 3 2017
End Date
January 28 2019
Last Update
January 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico, 14000